{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:03:41Z","timestamp":1789596221131,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1031440"],"award-info":[{"award-number":["OPP1031440"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.vaccine.2015.02.069","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T14:03:38Z","timestamp":1425909818000},"page":"1909-1915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model"],"prefix":"10.1016","volume":"33","author":[{"given":"Elizabeth B.","family":"Norton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise B.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.069_bib0195","series-title":"Poliomyelitis","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0200","first-page":"242","article-title":"Update on vaccine-derived polioviruses \u2013 worldwide, July 2012\u2013December 2013","volume":"63","author":"Diop","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0205","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1126\/science.343.6177.1302","article-title":"A war within a war","volume":"343","author":"Roberts","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0210","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/bmj.1.5237.1410","article-title":"Virus excretion after mass vaccination with attenuated polioviruses in Hungary","volume":"1","author":"Domok","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0215","first-page":"495","article-title":"Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates","volume":"65","author":"Heymann","year":"1987","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0220","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2010.11.043","article-title":"Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions","volume":"29","author":"Baldwin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0225","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1016\/j.vaccine.2012.09.059","article-title":"Adjuvants and inactivated polio vaccine: a systematic review","volume":"30","author":"Hawken","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0235","series-title":"Polio Eradication and Endgame Strategic Plan 2013\u20132018","author":"Global Polio Eradication Initiative","year":"2013"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/CVI.00538-10","article-title":"Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G\/L211A), as a safe and effective oral adjuvant","volume":"18","author":"Norton","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0245","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/CVI.00464-13","article-title":"Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli","volume":"20","author":"El-Kamary","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0250","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/IAI.00181-12","article-title":"The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens","volume":"80","author":"Norton","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0255","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0260","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2012.02.072","article-title":"Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen","volume":"30","author":"Hayden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0265","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.1302743","article-title":"Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes","volume":"192","author":"Heine","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0270","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/mi.2011.6","article-title":"Transcutaneous immunization as preventative and therapeutic regimens to protect against experimental otitis media due to nontypeable Haemophilus influenzae","volume":"4","author":"Novotny","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0275","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.vaccine.2012.10.033","article-title":"Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization","volume":"31","author":"Novotny","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0280","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.vaccine.2009.10.147","article-title":"Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin","volume":"28","author":"Summerton","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0285","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.4161\/hv.32253","article-title":"Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system","volume":"10","author":"White","year":"2014","journal-title":"Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0290","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.micinf.2014.07.013","article-title":"The immune response of two microbial antigens delivered intradermally, sublingually, or the combination thereof","volume":"16","author":"Lee","year":"2014","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0295","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/IAI.01394-13","article-title":"Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies","volume":"82","author":"Ruan","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0300","doi-asserted-by":"crossref","first-page":"e2683","DOI":"10.1371\/journal.pntd.0002683","article-title":"Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide","volume":"8","author":"Alam","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/CVI.00683-13","article-title":"Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine","volume":"21","author":"Kaminski","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.02.069_bib0310","first-page":"S540L 544","article-title":"Standardization of poliovirus neutralizing antibody tests","volume":"6","author":"Albrecht","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0315","series-title":"ImageJ","author":"Rasband","year":"1997"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0320","series-title":"Intradermal delivery of vaccines: a review of the literature and potential for development for use in low- and middle-income countries","author":"PATH","year":"2009"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0325","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0165-2478(01)00239-5","article-title":"Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells","volume":"78","author":"Cervenak","year":"2001","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0340","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.4049\/jimmunol.155.10.4575","article-title":"Analysis of thymic subpopulations expressing the activation antigen GL7. Expression, genetics, and function","volume":"155","author":"Hathcock","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0345","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/527487","article-title":"Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly","volume":"197","author":"Buisman","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/315684","article-title":"Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion","volume":"182","author":"Valtanen","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0355","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1128\/IAI.42.3.1041-1048.1983","article-title":"Immunoglobulin A-mediated hepatobiliary transport constitutes a natural pathway for disposing of bacterial antigens","volume":"42","author":"Russell","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0360","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.vaccine.2013.11.101","article-title":"A mucosal adjuvant for the inactivated poliovirus vaccine","volume":"32","author":"Steil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0365","doi-asserted-by":"crossref","first-page":"e100879","DOI":"10.1371\/journal.pone.0100879","article-title":"Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01","volume":"9","author":"Dietrich","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0370","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0375","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/intimm\/10.7.851","article-title":"Germinal center formation following immunization with the polysaccharide dextran B512 is substantially increased by cholera toxin","volume":"10","author":"Sverremark","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2015.02.069_bib0380","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1002881","article-title":"A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development","volume":"186","author":"Bemark","year":"2011","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T16:49:49Z","timestamp":1691513389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":38,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0264410X15002698"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}